06/15/2026
Depression and alcohol use disorder often go hand in hand, creating a cycle that can feel impossible to break. For many people, treating one condition without addressing the other leads to ongoing struggles and frustration.
New research is highlighting the potential of ketamine as a treatment that may help address both Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD), offering hope for individuals facing these challenging, co-occurring conditions. Researchers continue to explore ketamine's rapid antidepressant effects and its potential role in reducing alcohol cravings and improving overall outcomes for patients.
At Atlanta Ketamine Center, we understand that mental health challenges are rarely one-dimensional. Our goal is to provide compassionate, evidence-based care for individuals who have not found relief with traditional treatments.
If you or someone you love is struggling with depression and substance use, know that help is available and recovery is possible.
Read the article below to learn more about this emerging area of research.
https://www.psychiatryadvisor.com/news/ketamine-shows-dual-target-potential-for-patients-with-comorbid-mdd-and-aud/
In poster findings presented at the 2026 ASAM annual meeting, ketamine had rapid antidepressant effects and reduced alcohol-related measures.